bet9��

Skip to main content

Search

bet9��
Our Credo
Board of Directors

Committees of Board

Management Council
Manufacturing
Quality
Code of Conduct
Our History - bet9�� Archives
Milestones and Awards
Our Presence
Australia
Brazil
Europe

Malaysia
Morocco
Nepal

Sri Lanka
Uganda
Our Offerings
Our Therapies

Respiratory

Asthma
Paediatric Asthma
COPD
Nebulization

HIV/AIDS
Oncology
Other Therapies

bet9�� Generics

Products

Easylax
Easylax-L

bet9�� Diagnostics
API
Covid Care
Investors
Financials & Filings

Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement

Corporate Governance
Disclosure under regulation 46 of SEBI LODR
bet9�� at a Glance

Board Of Directors

Investor Resources
Shareholding Pattern
Intimation to Stock Exchange
Unclaimed Data
Investor Contacts
Disclaimer
Sustainability
Championing Climate Positivity
Accelerated Community Well-being

Community Initiatives
Employee Initiatives

Raising the Bar on Governance
Enhancing Access and Affordability
Careers
Life at bet9��
Business Functions
Diversity & Inclusion
Holistic Wellbeing
bet9�� University
Media Centre
Media Releases
In The News��
Leaders Speak
Corporate Social Responsibility
bet9�� Foundation

Annual Update 2023-24

CSR Policy
CSR Committee
Approved CSR Projects

2023-24
2022-23
2021-22
Contact Us
Global
Brazil

Sri Lanka

Breadcrumb

Home
media centre
news

In the news

Featured News

18 Feb 2025

05 Dec 2024

14 Nov 2024

11 Nov 2024

08 Nov 2024

08 Nov 2024

25 Sep 2024

Year

Search News

News 2025

18 Feb 2025

28 Jan 2025

06 Jan 2025

Corporate Information

bet9��
Board of Directors
Code of Conduct
Committees of the Board
Management Council
Sustainability
Manufacturing
Milestones and Awards
Our Credo
Our History - bet9�� Archives
Quality

Our Presence

Our Presence
Australia
Brazil
Europe
Malaysia
Morocco
Nepal
Sri Lanka

Our Offerings

Our Therapies
Respiratory
Asthma
Paediatric Asthma
COPD
Nebulization
HIV/AIDS
Oncology
bet9�� Generics
Our Offerings
bet9�� Diagnostics
API
Covid Care

Media

Media Center
Media Releases
In the News

Investor Information

Investors
Quarterly Results
Investor Presentation
Annual Reports
Corporate Governance
Disclosure under regulation 46 of SEBI
At a Glance
Board Of Directors
Committees of the Board
Investor Resources
Shareholding Pattern
Intimation to stock Exchanges
Unclaimed Data
Investor Contact
Disclaimer

Corporate Social Responsibility

CSR-bet9�� Foundation
CSR Policy
CSR Committee
Approved CSR Projects
- 2023-24
- 2022-23
- 2021-22

Career Sitemap

Careers
Life at bet9��
Business Functions
Diversity & Inclusion
Holistic Wellbeing
bet9�� University

Quick Links - Footer

Privacy Policy
Disclaimer
Contact Us
Sitemap
Caution Notice - Recruitment Fraud
Drug Safety Reporting

Chatbot API

Terms & Condition
Privacy Policy
Disclaimer
Terms of Use

Related Links

Remdesivir Supply Details - Maharashtra

© Copyright 2019 bet9��. All rights reserved

Digital Partner : Indus Net Technologies

Subscribe to bet9�� Newsletter

Email Address

Mobile Footer Menu

Remdesivir Supply Details - Maharashtra
Caution Notice - "Recruitment Fraud"
Contact Us
Disclaimer
Privacy Policy

© Copyright 2019��bet9��. All rights reserved

×

We use cookies on this site to enhance your user experience

By continuing to browse our website, you agree to the use of cookies. You can manage your cookie preferences by adjusting your browser settings. More info

Accept all Cookies